Sort
15,273 grants matching “antimicrobial resistance”
A machine learning-based screen of marine natural products to identify new leads for the treatment of Acanthamoeba eye infection
$237,000Anjan Debnath · University Of California, San Diego · R21 · FY2022 · EY
SIS Study of Aggressive versus Conservative Antimicrobial Initiation in the ICU
$237,000Robert G Sawyer · University Of Virginia · R34 · FY2014 · AI
Molecular Engineering of Humanized Anti-Staphlococcal Lytic Enzymes
$237,000Karl E Griswold · Dartmouth College · R21 · FY2012 · AI
Gonococcal Nuclease Mediated Escape from Neutrophil Extracellular Traps
$237,000Alison K Criss · University Of Virginia · R21 · FY2014 · AI
Mechanisms of Biofilm Antibiotic Resistance in Staphylococcus
$237,000Dartmouth College · R21 · FY2004 · AI
Novel Approaches to the Total Chemical Synthesis of Lasso Peptides as a Scaffold
$237,000Stephen B.h. Kent · University Of Chicago · R21 · FY2014 · AI
Biofilm Antibiotic Resistance in Staphylococcus
$237,000Dartmouth College · R21 · FY2003 · AI
High throughput screening to identify compounds against Entamoeba cysts
$237,000Upinder Singh · Stanford University · R21 · FY2016 · AI
Desiccation resistance in Coxiella burnetii
$237,000Howard A Shuman · University Of Chicago · R21 · FY2015 · AI
Adenosine receptor-mediated effects of Clostridium difficile toxins in humans
$237,000Cirle Alcantara Warren · University Of Virginia · R21 · FY2016 · AI
Polymer-Antibiotic Conjugates as Antibacterial Additives for Dental Resins
$236,958Chong Cheng · State University Of New York At Buffalo · R21 · FY2019 · DE
Electronic Communication for Antimicrobial Management (ECAM)
$236,912Robert Stanley Hum · Columbia University Health Sciences · R21 · FY2008 · NR
Predictions of Response to Treatment in Fungal Keratitis
$236,815Jennifer Rose-Nussbaumer · University Of California, San Francisco · K23 · FY2015 · EY
Fecal Bacteriotherapy for Relapsing Clostridium difficile Infection
$236,814Colleen Renee Kelly · Miriam Hospital · R21 · FY2012 · DK
Nanofiber-based Delivery of Combined Immune-modulating Compounds to Minimize Infection and Enhance Wound Healing
$236,810Jingwei Xie · University Of Nebraska Medical Center · R01 · FY2023 · GM
Mechanisms of cefiderocol resistance
$236,750Yohei Doi · University Of Pittsburgh At Pittsburgh · R21 · FY2020 · AI
Phages as drivers of pathogenicity: selective impacts and molecular targets of clinical Pseudomonas aeruginosa phages
$236,700Marvin Whiteley · Georgia Institute Of Technology · R21 · FY2019 · AI
iCAP An Innovative Device to Rapidly Resolve Microbial Keratitis
$236,524Anjal C Sharma · Lynntech, Inc. · R43 · FY2016 · EY
Host-Targeted Homoserine Lactone Inhibitor as Adjunctive Antipseudomonal Therapy
$236,500Peter Michael Haggie · University Of California, San Francisco · R21 · FY2014 · AI
Predictions of Response to Treatment in Fungal Keratitis
$236,346Jennifer Rose-Nussbaumer · University Of California, San Francisco · K23 · FY2016 · EY
Synthesis of natural product scaffold selectively active against dormant Mycobacterium tuberculosis
$236,325Steven Sucheck · University Of Toledo · R21 · FY2018 · AI
Spin-Labeled Peptide Antibiotics
$236,304Jimmy Feix · Medical College Of Wisconsin · R01 · FY2007 · GM
Alteration of bronchial epithelium host defenses by marijuana and vaping preparations
$236,250Estelle A Cormet-Boyaka · Ohio State University · R21 · FY2024 · DA
Lifelong Triclosan Exposure and Fatty Liver Disease
$236,250Robert H Tukey · University Of California, San Diego · R21 · FY2020 · ES
Interferon-mediated control mechanisms in human cells
$236,250L David Sibley · Washington University · R21 · FY2020 · AI